Stay updated on Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A banner announces an NIH website terminology transition, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.” The clinical trial record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T18:22:26.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T20:31:57.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision number changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T20:43:24.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with the standard site header and footer. The study-related content (investigators, sponsor, locations, and detailed study information) has been removed in this view.
    Difference
    19%
    Check dated 2026-09-19T22:06:16.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Footer and navigation content updated with revision information (v3.6.6), release notes, and a Study Protocol/SAP PDF reference; these additions are global site elements rather than changes to the study details themselves.
    Difference
    100%
    Check dated 2026-09-05T20:11:09.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page shows a new revision tag, updating from v3.6.5 to v3.6.6, indicating a small backend or content update to the page. This update does not modify the study details or other user-facing information.
    Difference
    0.1%
    Check dated 2026-08-29T18:46:16.000Z thumbnail image

Stay in the know with updates to Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.